Martine Rothblatt
2009
In 2009, Martine Rothblatt earned a total compensation of $17.6M as Chief Executive Officer at United Therapeutics, a 216% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,755,503 |
|---|---|
| Non-Equity Incentive Plan | $440,125 |
| Option Awards | $14,577,981 |
| Salary | $798,203 |
| Other | $19,286 |
| Total | $17,591,098 |
Rothblatt received $14.6M in option awards, accounting for 83% of the total pay in 2009.
Rothblatt also received $1.8M of change in pension value and nonqualified deferred compensation earnings, $440.1K in non-equity incentive plan, $798.2K in salary and $19.3K in other compensation.
Rankings
In 2009, Martine Rothblatt's compensation ranked 74th out of 9,885 executives tracked by ExecPay. In other words, Rothblatt earned more than 99.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 74 out of 9,885 | 99th |
Division Manufacturing | 24 out of 3,690 | 99th |
Major group Chemicals And Allied Products | 10 out of 871 | 99th |
Industry group Drugs | 10 out of 643 | 98th |
Industry Pharmaceutical Preparations | 10 out of 446 | 98th |
Source: SEC filing on April 30, 2012.
Rothblatt's colleagues
We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2009.